DioGenix Gets Prescribed $1.5M
DioGenix, the Gaithersburg, Maryland-based molecular diagnostics company, announced it has raised $1.5 million. Nerveda LLC, a life science fund, participated in the Series B round.
19 December 2012•3 mins read
DioGenix, the Gaithersburg, Maryland-based molecular diagnostics company, announced it has raised $1.5 million. Nerveda LLC, a life science fund, participated in the Series B round.
